Skip to main content

Table 1 Baseline characteristics of the study subjects

From: Chungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanism

Characteristic

CYT Medication

(N = 47)

Female sex, n (%)

30 (64)

Age, year (SD)

62.9 (13.9)

Time since stroke, day (SD)

2.1 (1.6)

Admitting day (SD)

24.7 (18.4)

Medical history

 

   Hypertension, n (%)

26 (55)

   Diabetes Mellitus, n (%)

10 (21)

Social history

 

   Smoking, n(%)

14 (30)

   Alcohol, n(%)

16 (34)

Motor grade (upper limb) (SD)

3.8 (1.5)

Motor grade (lower limb) (SD)

3.8 (1.4)

NIH Stroke Scale (SD)

3.6 (4.1)

Modified Barthel Index (SD)

72.4 (32.9)

  1. CYT, Chungsim-Yeunja-Tang; SD, standard deviation; FBS, fasting blood sugar; LDL-c, low density lipoprotein cholesterol. CYT was administrated orally for 2 weeks.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094